Chescapmanager’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AWA
Chescapmanager's BMY Position: Q4 2022 in Review
Chescapmanager sold out of Bristol-Myers Squibb (BMY) in Q4 2022, closing a stake of 90,852 shares — an estimated $6.46M sold.
Chescapmanager first reported a position in BMY in Q1 2017 and held it in 21 quarters. The position peaked at $29.8M in Q2 2021. 2,600 funds tracked by Wall St. Rank hold BMY as of Q4 2022.
- Chescapmanager reported no remaining Bristol-Myers Squibb position as of Q4 2022 after selling out during the quarter.
- Chescapmanager sold 90,852 Bristol-Myers Squibb shares in Q4 2022, an estimated $6.46M.
- Chescapmanager first reported a position in Bristol-Myers Squibb in Q1 2017 and held it in 21 quarters.
- Chescapmanager's Bristol-Myers Squibb position peaked at $29.8M in Q2 2021.
- 2,600 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2022.
Based on Chescapmanager's 13F filing for Q4 2022, filed 14 Feb 2023.